Pages Menu
Twitter
Categories Menu

Posted by on Feb 10, 2012 in Pharma

Drug R&D Now $4 Billion per Approved Pill?

Drug R&D Now $4 Billion per Approved Pill?

Dollar.jpgForbes’s Matthew Herper recalculates the cost of drug development and comes up with an average of $4 billion per approved drugwhich is $3 billion more than the oft-cited number of $1 billion (from the oft-cited DiMasi study). Moreover, some companies (Amgen, Novartis) have been a whole lot betteror a whole lot luckierat parlaying their R&D investment into marketable products. AstraZeneca, with a nearly $12-billion-per-approved-pill cost: Eh, not so much.

bmartin (1127 Posts)

A native East Tennessean, Barbara Martin is a formerly practicing, board-certified neurologist who received her BS (psychology, summa cum laude) and MD from Duke University before completing her postgraduate training (internship, residency, fellowship) at the Hospital of the University of Pennsylvania in Philadelphia. She has worked in academia, private practice, medical publishing, drug market research, and continuing medical education (CME). For the last 3 years, she has worked in a freelance capacity as a medical writer, analyst, and consultant. Follow Dr. Barbara Martin on and Twitter.